<DOC>
	<DOC>NCT00911105</DOC>
	<brief_summary>Purpose of this non-interventional study is the documentation of efficacy and safety data of multiple myeloma therapy with a combined treatment of Lenalidomide and Dexamethasone in daily routine practice.</brief_summary>
	<brief_title>Non -Interventional Study-Palliative Therapy of Multiple Myeloma With a Combination of Lenalidomide and Dexamethasone</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms, Plasma Cell</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<criteria>Patients with multiple myeloma with at least one previous therapy. 18 years or older Signed, written informed consent Pregnancy or nursing All other exclusion criteria listed in SmPC (summary of product characteristics)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Multiple Myeloma</keyword>
	<keyword>Non-interventional study</keyword>
	<keyword>Lenalidomide</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>Observational</keyword>
	<keyword>Time to progression</keyword>
	<keyword>Clinical routine</keyword>
	<keyword>Germany</keyword>
	<keyword>Plasmacytoma</keyword>
</DOC>